Search research articles
Contact Us
Filters
Showing results (841-850 of 996) with videos related to
Page
of 100
Sort By:
Therapeutic Advances in Medical Oncology
|
November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness
Haoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
Histopathology
|
September 15, 2020
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours
Kris G Samsom, Sonja Levy, Linde M van Veenendaal, et al.
Clinical and Translational Gastroenterology
|
May 18, 2022
Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
Zheng Feng, Cary J G Oberije, Alouisa J P van de Wetering, et al.
Oncotarget
|
October 13, 2016
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
Evert van den Broek, Oscar Krijgsman, Daoud Sie, et al.
Plos One
|
August 1, 2012
Comprehensive mutation analysis in colorectal flat adenomas
Quirinus J M Voorham, Beatriz Carvalho, Angela J Spiertz, et al.
BMC Medical Genomics
|
June 3, 2009
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck
Saskia M Wilting, Serge J Smeets, Peter J F Snijders, et al.
Endoscopy International Open
|
May 11, 2019
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
Jasper L A Vleugels, Sanne M van Neerven, Monique E van Leerdam, et al.
ESMO Open
|
January 3, 2026
Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy
I A Franken, F Heilijgers, M-C E Bakker, et al.
Plos One
|
August 8, 2009
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer
Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, et al.
Thorax
|
November 15, 2013
DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer
Robert A A van Boerdonk, Johannes M A Daniels, Peter J F Snijders, et al.
Page
of 100
Search research articles
Search
Showing results (841-850 of 996) with videos related to
Sort By:
Page
of 100
Therapeutic Advances in Medical Oncology
|
November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness
Haoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
Histopathology
|
September 15, 2020
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours
Kris G Samsom, Sonja Levy, Linde M van Veenendaal, et al.
Clinical and Translational Gastroenterology
|
May 18, 2022
Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
Zheng Feng, Cary J G Oberije, Alouisa J P van de Wetering, et al.
Oncotarget
|
October 13, 2016
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
Evert van den Broek, Oscar Krijgsman, Daoud Sie, et al.
Plos One
|
August 1, 2012
Comprehensive mutation analysis in colorectal flat adenomas
Quirinus J M Voorham, Beatriz Carvalho, Angela J Spiertz, et al.
BMC Medical Genomics
|
June 3, 2009
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck
Saskia M Wilting, Serge J Smeets, Peter J F Snijders, et al.
Endoscopy International Open
|
May 11, 2019
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
Jasper L A Vleugels, Sanne M van Neerven, Monique E van Leerdam, et al.
ESMO Open
|
January 3, 2026
Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy
I A Franken, F Heilijgers, M-C E Bakker, et al.
Plos One
|
August 8, 2009
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer
Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, et al.
Thorax
|
November 15, 2013
DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer
Robert A A van Boerdonk, Johannes M A Daniels, Peter J F Snijders, et al.
Page
of 100